You have access
Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel KIF5B–ALK Fusion Oncokinase
NAOKI SHIMIZU, YUSAKU AKASHI, TOMOMI FUJII, HIROYUKI SHIONO, KATSUNARI YANE, TADASHI KITAHARA, YOSHIO OHTA, KENNICHI KAKUDO and TOMOKO WAKASA
Anticancer Research January 2019, 39 (1) 413-420; DOI: https://doi.org/10.21873/anticanres.13127